| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Antipseudomonal treatment decisions during CF exacerbation management
|
VanDevanter, D.R.
|
|
|
21 |
5 |
p. 753-758
|
artikel
|
| 2 |
Association between stool consistency and clinical variables among infants with cystic fibrosis: Findings from the BONUS study
|
Freeman, A. Jay
|
|
|
21 |
5 |
p. 830-836
|
artikel
|
| 3 |
Bone mineral density screening by DXA for people with cystic fibrosis: A registry analysis of patient and program factors influencing rates of screening
|
Ratti, Gregory A.
|
|
|
21 |
5 |
p. 784-791
|
artikel
|
| 4 |
Caution advised in the use of CFTR modulator treatment for individuals harboring specific CFTR variants
|
Raraigh, Karen S.
|
|
|
21 |
5 |
p. 856-860
|
artikel
|
| 5 |
CFTR dysfunction and targeted therapies: A vision from non-cystic fibrosis bronchiectasis and COPD
|
Martinez-Garcia, Miguel Angel
|
|
|
21 |
5 |
p. 741-744
|
artikel
|
| 6 |
Change in exercise capacity measured by Cardio-pulmonary Exercise Testing (CPET) in Danish people with cystic fibrosis after initiation of treatment with Lumacaftor/Ivacaftor and Tezacaftor/Ivacaftor
|
Rysgaard, Ulla Kildall
|
|
|
21 |
5 |
p. 844-849
|
artikel
|
| 7 |
Changes in airway bacterial communities occur soon after initiation of antibiotic treatment of pulmonary exacerbations in cystic fibrosis
|
Carmody, Lisa A.
|
|
|
21 |
5 |
p. 766-768
|
artikel
|
| 8 |
Chronic rhinosinusitis in people with Cystic Fibrosis: Expanding evidence and future directions
|
Beswick, Daniel M
|
|
|
21 |
5 |
p. 737-738
|
artikel
|
| 9 |
Clinical outcomes of a large cohort of individuals with the F508del/5T;TG12 CFTR genotype
|
Tosco, Antonella
|
|
|
21 |
5 |
p. 850-855
|
artikel
|
| 10 |
Club cell secretory protein and lung function in children with cystic fibrosis
|
Zhai, Jing
|
|
|
21 |
5 |
p. 811-820
|
artikel
|
| 11 |
Corrigendum to “Using a learning health system to understand the mismatch between medicines supply and actual medicines use among adults with cystic fibrosis” [J Cyst Fibros (2022), 21/2, 323-331]
|
Bevan, Amanda
|
|
|
21 |
5 |
p. 893-897
|
artikel
|
| 12 |
Current prices versus minimum costs of production for CFTR modulators
|
Guo, Jonathan
|
|
|
21 |
5 |
p. 866-872
|
artikel
|
| 13 |
2D Shear Wave Elastography, a promising screening tool for Cystic Fibrosis liver disease, shows a correlation between vitamin D and liver stiffness
|
H, Elidottir
|
|
|
21 |
5 |
p. 873-877
|
artikel
|
| 14 |
Editorial Board
|
|
|
|
21 |
5 |
p. ii
|
artikel
|
| 15 |
Elexacaftor-Tezacaftor-Ivacaftor improve Gastro-Oesophageal reflux and Sinonasal symptoms in advanced cystic fibrosis
|
Shakir, Sufyan
|
|
|
21 |
5 |
p. 807-810
|
artikel
|
| 16 |
Elexacaftor-Tezacaftor- Ivacaftor improves sinonasal outcomes in cystic fibrosis
|
Stapleton, Amanda L.
|
|
|
21 |
5 |
p. 792-799
|
artikel
|
| 17 |
ELX/TEZ/IVA use in cystic fibrosis liver disease: Is the perspective of improved lung function worth the risk?
|
Gardiner, A.
|
|
|
21 |
5 |
p. 881-884
|
artikel
|
| 18 |
Ethmoidal mucocele causing proptosis in a pediatric patient with cystic fibrosis: A case report
|
de Manuel Gómez, Cristina
|
|
|
21 |
5 |
p. 878-880
|
artikel
|
| 19 |
Evaluating the alginate oligosaccharide (OligoG) as a therapy for Burkholderia cepacia complex cystic fibrosis lung infection
|
Fischer, Rianald
|
|
|
21 |
5 |
p. 821-829
|
artikel
|
| 20 |
Impact of highly effective CFTR modulator therapy on digital clubbing in patients with cystic fibrosis
|
Mahlen, Tsaina
|
|
|
21 |
5 |
p. 861-865
|
artikel
|
| 21 |
Incidence of breast cancer in people with cystic fibrosis: A cause for concern?
|
FitzMaurice, Thomas Simon
|
|
|
21 |
5 |
p. 890
|
artikel
|
| 22 |
Modulation, microbiota and inflammation in the adult CF gut: A prospective study
|
Ronan, NJ
|
|
|
21 |
5 |
p. 837-843
|
artikel
|
| 23 |
News article
|
|
|
|
21 |
5 |
p. 729-731
|
artikel
|
| 24 |
Next steps on managing pulmonary exacerbations: Is the future less, shorter and or more targeted treatments?
|
Smith, Daniel J
|
|
|
21 |
5 |
p. 739-740
|
artikel
|
| 25 |
No patient left behind! Therapeutic options for cystic fibrosis patients living with lung transplantation
|
Tissot, Adrien
|
|
|
21 |
5 |
p. 735-736
|
artikel
|
| 26 |
Nutritional status and lung function in children with pancreatic-sufficient cystic fibrosis
|
Madde, Ankitha
|
|
|
21 |
5 |
p. 769-776
|
artikel
|
| 27 |
Obesity in Cystic fibrosis: prevalence, trends and associated factors data from the US cystic fibrosis foundation patient registry
|
Szentpetery, Sylvia
|
|
|
21 |
5 |
p. 777-783
|
artikel
|
| 28 |
Onset of systemic arterial hypertension after initiation of elexacaftor/tezacaftor/ivacaftor in adults with cystic fibrosis: A case series
|
Gramegna, Andrea
|
|
|
21 |
5 |
p. 885-887
|
artikel
|
| 29 |
Staphylococcus aureus detection from CF respiratory samples is improved using alternative media
|
Zirbes, Christian F.
|
|
|
21 |
5 |
p. 888-889
|
artikel
|
| 30 |
Testicular cancer in men with cystic fibrosis
|
Maisonneuve, Patrick
|
|
|
21 |
5 |
p. 891-892
|
artikel
|
| 31 |
The effect of antibiotic changes during treatment of cystic fibrosis pulmonary exacerbations
|
Zikic, Andrew
|
|
|
21 |
5 |
p. 759-765
|
artikel
|
| 32 |
The negative impact of chronic rhinosinusitis on the health-related quality of life among adult patients with cystic fibrosis
|
Lee, Daniel J.
|
|
|
21 |
5 |
p. 800-806
|
artikel
|
| 33 |
Time to change course and tackle CF related obesity
|
Caley, Laura
|
|
|
21 |
5 |
p. 732-734
|
artikel
|
| 34 |
Use of elexacaftor/tezacaftor/ivacaftor among cystic fibrosis lung transplant recipients
|
Ramos, Kathleen J.
|
|
|
21 |
5 |
p. 745-752
|
artikel
|
Tijdschrift beschrijving